Esperion Therapeutics
ESPR
#6580
Rank
C$1.15 B
Marketcap
C$4.50
Share price
-0.16%
Change (1 day)
235.42%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -C$39.65 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.30 Billion. In 2024 the company made an earning of C$10.66 Million, an increase over its 2023 earnings that were of -C$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$39.65 Million-471.72%
2024 C$10.66 M-104.99%
2023 -C$0.22 Billion-15.03%
2022 -C$0.26 Billion-20.61%
2021 -C$0.32 Billion84.28%
2020 -C$0.18 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.29 Billion19.57%
2017 -C$0.24 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$70.01 Million36.45%
2014 -C$51.31 Million43.55%
2013 -C$35.74 Million145.26%
2012 -C$14.58 Million
2002 -C$41.55 Million-7.81%
2001 -C$45.07 Million15.03%
2000 -C$39.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$15.04 B-38,695.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.32 B-18,892.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-C$0.77 Billion 1,855.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$97.45 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.27 M-100.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54 B-1,505.17%๐Ÿ‡บ๐Ÿ‡ธ USA